Qlucore AB (publ) - Asset Resilience Ratio

Latest as of December 2011: 0.17%

Qlucore AB (publ) (NOVKAN) has an Asset Resilience Ratio of 0.17% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NOVKAN working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr67.00K

≈ $7.21K USD Cash + Short-term Investments

Total Assets

Skr39.74 Million

≈ $4.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2011)

This chart shows how Qlucore AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NOVKAN current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Qlucore AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read NOVKAN liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr67.00K	0.17%
Total Liquid Assets	Skr67.00K	0.17%

Asset Resilience Insights

Limited Liquidity: Qlucore AB (publ) maintains only 0.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qlucore AB (publ) Industry Peers by Asset Resilience Ratio

Compare Qlucore AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Hugel Inc KQ:145020	Biotechnology	29.57%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	2.30%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Beijing Scitop Bio Tech Co Ltd SHE:300858	Biotechnology	25.93%

Annual Asset Resilience Ratio for Qlucore AB (publ) (2010–2011)

The table below shows the annual Asset Resilience Ratio data for Qlucore AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2011-12-31	0.17%	Skr67.00K ≈ $7.21K	Skr39.74 Million ≈ $4.28 Million	-3.40pp
2010-12-31	3.57%	Skr500.00K ≈ $53.81K	Skr14.01 Million ≈ $1.51 Million	--

pp = percentage points

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#31148 Global

#6265 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23